SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,264.51 330.92
( 0.43%)

Global Indices

Nasdaq

53,583.69 98.81
(0.18%)

Dow Jones

7,750.97 54.27
(0.71%)

Hang Seng

66,369.62 237.64
(0.36%)

Nikkei 225

10,795.58 -82.54
(-0.76%)

Forex

USD-INR

95.26 -0.05
(-0.05%)

EUR-INR

111.07 -0.11
(-0.10%)

GBP-INR

129.70 -0.28
(-0.21%)

JPY-INR

0.60 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Curis Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

94348

INE1BZN01016

58.5748291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CURIS

14.58

101.02

EPS(TTM)

Face Value()

Div & Yield %

8.57

Back

Forbes & Company consolidated net profit declines 25.93% in the June 2026 quarter

Aug 14,2026

Net profit of Forbes & Company declined 25.93% to Rs 3.60 crore in the quarter ended June 2026 as against Rs 4.86 crore during the previous quarter ended June 2025. Sales declined 40.94% to Rs 13.26 crore in the quarter ended June 2026 as against Rs 22.45 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	13.26	22.45	-41
OPM %	8.45	5.12	-
PBDT	4.64	6.33	-27
PBT	4.10	5.76	-29
NP	3.60	4.86	-26

77,264.51 330.92 ( 0.43%)

53,583.69 98.81 (0.18%)

7,750.97 54.27 (0.71%)

66,369.62 237.64 (0.36%)

10,795.58 -82.54 (-0.76%)

95.26 -0.05 (-0.05%)

111.07 -0.11 (-0.10%)

129.70 -0.28 (-0.21%)

0.60 0.00 (0.01%)